MAPS Bulletin Autumn 1994 Vol. 05, No. 2 Building Towards Clinical Trials
Dr. Rick Strassman of the University of New Mexico at Albuquerque has now begun his Phase 1 study of the physiological and psychological effects of psilocybin in human volunteers. These experiments are being conducted with a standard dose-response design. Dr. Strassman is also continuing with his studies of DMT. The next issue of the MAPS Bulletin will contain a report by Dr. Strassman on these studies.